|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
258,990,000 |
Market
Cap: |
19.30(B) |
Last
Volume: |
1,186,610 |
Avg
Vol: |
1,898,196 |
52
Week Range: |
$65.11 - $82.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 317 |
Guru Rank Value : 4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
16,441 |
67,902 |
123,113 |
368,767 |
Total Sell Value |
$1,241,296 |
$5,004,391 |
$8,902,469 |
$27,563,219 |
Total People Sold |
1 |
4 |
6 |
10 |
Total Sell Transactions |
1 |
6 |
8 |
16 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Thornal Kevin R |
Div. President, DiagnosticsOff |
|
2019-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,554 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2019-06-03 |
4 |
AS |
$44.07 |
$200,298 |
D/D |
(4,545) |
50,353 |
|
- |
|
Crawford Sally |
Director |
|
2019-03-18 |
4 |
AS |
$47.61 |
$585,889 |
D/D |
(12,306) |
156,580 |
|
- |
|
Crawford Sally |
Director |
|
2019-03-18 |
4 |
OE |
$20.01 |
$246,243 |
D/D |
12,306 |
168,886 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2019-03-11 |
4 |
S |
$46.70 |
$318,961 |
D/D |
(6,830) |
15,172 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2019-03-11 |
4 |
OE |
$19.86 |
$135,644 |
D/D |
6,830 |
22,002 |
|
- |
|
Wendell Amy Mcbride |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
12,433 |
|
- |
|
Garrett Scott T |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
24,964 |
|
- |
|
Crawford Sally |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
156,580 |
|
- |
|
Hantson Ludwig |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
2,795 |
|
- |
|
Nawana Namal |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
11,496 |
|
- |
|
Stamoulis Christiana |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
37,175 |
|
- |
|
Dockendorff Charles J |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
19,912 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2019-03-01 |
4 |
S |
$47.38 |
$200,986 |
D/D |
(4,242) |
54,898 |
|
- |
|
Griffin John M. |
General Counsel |
|
2019-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,376 |
83,473 |
|
- |
|
Bebo Allison P |
SVP, Human Resources |
|
2019-02-02 |
4 |
D |
$43.70 |
$25,739 |
D/D |
(589) |
23,019 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2018-12-07 |
4 |
S |
$42.20 |
$200,028 |
D/D |
(4,740) |
59,140 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2018-12-04 |
4 |
D |
$43.90 |
$150,314 |
D/D |
(3,424) |
1,565,815 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2018-12-01 |
4 |
D |
$44.41 |
$741,425 |
D/D |
(16,695) |
1,569,239 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2018-12-01 |
4 |
D |
$44.41 |
$22,294 |
D/D |
(502) |
14,993 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2018-12-01 |
4 |
D |
$44.41 |
$68,480 |
D/D |
(1,542) |
63,880 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2018-12-01 |
4 |
D |
$44.41 |
$21,361 |
D/D |
(481) |
18,267 |
|
- |
|
West Thomas A. |
Div President & GM, Diagnostic |
|
2018-12-01 |
4 |
D |
$44.41 |
$44,899 |
D/D |
(1,011) |
55,753 |
|
- |
|
Bebo Allison P |
SVP, Human Resources |
|
2018-12-01 |
4 |
D |
$44.41 |
$50,094 |
D/D |
(1,128) |
23,608 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2018-11-30 |
4 |
S |
$44.49 |
$444,870 |
D/D |
(10,000) |
15,495 |
|
- |
|
1698 Records found
|
|
Page 14 of 68 |
|
|